BioCryst Announces Approval of ORLADEYO® (berotralstat) in Saudi Arabia | Nation/World
RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2022 (GLOBE NEWSWIRE) -- BioCryst Prescribed drugs, Inc. (Nasdaq: BCRX) at this time introduced that ...
Tag: BioCryst
RESEARCH TRIANGLE PARK, N.C., Aug. 18, 2022 (GLOBE NEWSWIRE) -- BioCryst Prescribed drugs, Inc. (Nasdaq: BCRX) at this time introduced that ...